Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins

BACKGROUND: Despite the high cardiovascular risk, evidence of efficacy of preventive strategies in individuals with diabetes is scant. In particular, recommendations on the use of aspirin in patients with diabetes mostly reflect an extrapolation from data deriving from other high risk populations. F...

Descripción completa

Detalles Bibliográficos
Autores principales: De Berardis, Giorgia, Sacco, Michele, Evangelista, Virgilio, Filippi, Alessandro, Giorda, Carlo B, Tognoni, Gianni, Valentini, Umberto, Nicolucci, Antonio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014771/
https://www.ncbi.nlm.nih.gov/pubmed/17725825
http://dx.doi.org/10.1186/1745-6215-8-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014771/
https://www.ncbi.nlm.nih.gov/pubmed/17725825
http://dx.doi.org/10.1186/1745-6215-8-21

Ejemplares similares